OMEROS CORP (OMER)

↓ Download CSV

CIK 0001285819 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated WA
  • Fiscal year ends Dec 31
Metric (FY)2025202420232022202120202019201820172016
Revenue$73.81M$111.81M$29.87M$64.83M
Cost of Revenue$902.0K$865.0K$512.0K$1.08M$1.41M
Operating Income-$122.80M-$166.95M-$164.53M-$163.39M-$173.62M-$156.92M-$146.04M-$112.22M-$43.90M-$54.28M
Net Income-$3.35M-$156.81M-$117.81M$47.42M$194.24M-$138.06M-$84.49M-$126.76M-$53.48M-$66.75M
EPS (Diluted)$-0.05$-2.70$-1.88$0.76$3.12$-2.41$-1.71
Total Assets$325.63M$277.08M$378.27M$590.97M$419.27M$181.04M$136.97M$95.94M$116.33M$67.28M
Shareholders' Equity-$121.23M-$182.61M-$24.98M$85.68M$23.78M-$120.75M-$109.02M-$100.16M-$2.81M-$37.45M
Cash & Equivalents$9.66M$3.40M$7.11M$11.01M$100.81M$10.50M$3.08M$5.86M$3.39M$2.22M
Operating Cash Flow-$116.09M-$148.80M$74.73M-$86.48M-$109.72M-$100.09M-$60.07M-$103.74M-$36.23M-$51.50M
Capital Expenditures$65.0K$165.0K$426.0K$113.0K$277.0K$283.0K$334.0K$567.0K$350.0K$126.0K
Shares Outstanding71.67M58.04M61.13M62.83M62.63M61.67M54.20M49.01M48.21M43.82M